Financials American Oncology Network, Inc.
Equities
AONC
US0287191029
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.34 USD | +19.15% | +41.53% | -43.39% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | - | - | 56.35 |
Enterprise Value (EV) 1 | - | - | 125.3 |
P/E ratio | - | - | -4.32 x |
Yield | - | - | - |
Capitalization / Revenue | - | - | 0.04 x |
EV / Revenue | - | - | 0.04 x |
EV / EBITDA | - | - | -12.1 x |
EV / FCF | - | - | 2,949,166 x |
FCF Yield | - | - | 0% |
Price to Book | - | - | -0.35 x |
Nbr of stocks (in thousands) | - | - | 9,550 |
Reference price 2 | 9.750 | 10.04 | 5.900 |
Announcement Date | 23-01-06 | 23-04-28 | 24-03-28 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 319.9 | 717.9 | 943.7 | 1,150 | 1,279 |
EBITDA 1 | 4.615 | 18.89 | 6.99 | 12.28 | -4.668 |
EBIT 1 | 3.607 | 15.23 | 0.911 | 5.566 | -13.12 |
Operating Margin | 1.13% | 2.12% | 0.1% | 0.48% | -1.03% |
Earnings before Tax (EBT) 1 | 2.528 | 21.17 | 0.355 | 2.589 | -35.69 |
Net income 1 | 2.773 | 21.95 | -0.105 | 2.589 | -5.542 |
Net margin | 0.87% | 3.06% | -0.01% | 0.23% | -0.43% |
EPS | - | - | - | - | -1.365 |
Free Cash Flow | - | - | -44.06 | -0.4669 | 19.11 |
FCF margin | - | - | -4.67% | -0.04% | 1.49% |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 23-01-06 | 23-01-06 | 23-01-06 | 23-04-28 | 24-03-28 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt | - | - | 36.3 | 92 | 68.9 |
Net Cash position | - | 6.34 | - | - | - |
Leverage (Debt/EBITDA) | - | - | 5.199 x | 7.486 x | -14.77 x |
Free Cash Flow | - | - | -44.1 | -0.47 | 19.1 |
ROE (net income / shareholders' equity) | - | - | -0.18% | 4.26% | -54.4% |
ROA (Net income/ Total Assets) | - | - | 0.25% | 1.21% | -2.34% |
Assets 1 | - | - | -41.42 | 213.8 | 236.8 |
Book Value Per Share | - | - | - | - | -17.00 |
Cash Flow per Share | - | - | - | - | 3.000 |
Capex 1 | 11.6 | 12.2 | 8.32 | 7.19 | 12.3 |
Capex / Sales | 3.63% | 1.7% | 0.88% | 0.63% | 0.96% |
Announcement Date | 23-01-06 | 23-01-06 | 23-01-06 | 23-04-28 | 24-03-28 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-43.39% | 24.7M | |
+22.65% | 87.14B | |
-23.68% | 75.59B | |
+1.76% | 26.78B | |
+3.99% | 17.89B | |
-13.47% | 16.44B | |
+2.68% | 15.68B | |
+69.13% | 13.3B | |
+74.99% | 13.06B | |
+3.11% | 12.54B |
- Stock Market
- Equities
- AONC Stock
- Financials American Oncology Network, Inc.